Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does teriparatide given in combination with menopausal hormone replacement therapy improve bone mineral density?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 430–431 (2006)Cite this article

boxed-textSte-Marie LG et al. (2006) Effect of teriparatide [rhPTH(1–34)] on BMD when given to postmenopausal women receiving hormone replacement therapy. J Bone Miner Res 21: 283–291

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Neer RM et al. (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 1434–1441

    Article  CAS  Google Scholar 

  2. Rossouw JE et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321–333

    Article  CAS  Google Scholar 

  3. Black DM et al. (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349: 1207–1215

    Article  CAS  Google Scholar 

  4. Finkelstein JS et al. (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349: 1216–1226

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Ian Newman, Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Medicine and Associate Director for Research at the Mayo Clinic College of Medicine, Rochester, MN, USA

    Sundeep Khosla

Authors
  1. Sundeep Khosla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sundeep Khosla.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khosla, S. Does teriparatide given in combination with menopausal hormone replacement therapy improve bone mineral density?. Nat Rev Endocrinol 2, 430–431 (2006). https://doi.org/10.1038/ncpendmet0243

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0243

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing